Effect of Sphatika bhasma on Wound
Not Applicable
- Conditions
- Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
- Registration Number
- CTRI/2023/05/053237
- Lead Sponsor
- Government Ayurvedic College, Patna
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient willing for trial.
On the basis of sign & symptoms seen of vrana (wound or ulcer)
Exclusion Criteria
Patient associated with chronic disease like AIDS, Cancer,Hepatitis B, T.B, Cardiac Complications, Diabetic, Pregnant Lactating women etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relief of symptoms like size,colour,symmetry,pain,tenderness,swelling,bleeding,Descharge of serum,odour,Itching etc. <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: 30 Days
- Secondary Outcome Measures
Name Time Method Releif in sign and symptoms of vrana before and after treatment.Timepoint: 30 Days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Sphatika bhasma's anti-inflammatory and antimicrobial effects on wound healing?
How does Sphatika bhasma compare to conventional wound treatments like silver sulfadiazine in clinical efficacy for L089 skin infections?
Are there specific biomarkers (e.g., cytokine profiles, microbial load) that predict response to Sphatika bhasma in chronic wound management?
What adverse events are associated with Sphatika bhasma application in skin infections, and how do they compare to Ayurvedic wound therapies?
What combination approaches with Sphatika bhasma (e.g., neem, turmeric) show synergistic wound healing in preclinical or clinical studies?